Caricamento...
Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the opportunities to use this molecule in new pharmaceutical formulations to combat type 2 diabetes and metabolic syndrome. It is well known that HIV is per se a condition of insulin resistance and in particular the patient w...
Salvato in:
| Pubblicato in: | J Transl Int Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
De Gruyter Open
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5290891/ https://ncbi.nlm.nih.gov/pubmed/28191538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jtim-2016-0026 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|